Early detection is important for improving outcomes in chronic diseases. Current biomarker analysis still depends heavily on collecting limited samples, processing them outside the body, and waiting for results. This can miss rare early signals when disease related biomarkers are present at very low concentrations.

BeNiFIt explores whether intrabody nanoscale communication can make in vivo biomarker detection more feasible. Its long term vision is faster, less invasive, and more continuous biomarker monitoring. The fellowship work focused on modelling, simulation, communication design, and reusable research methods.